AI for Personalised Risk Prediction and Causal Understanding in Skin Cancer
Skin cancer is an increasing healthcare challenge, highlighting the need for better ways to identify people at elevated risk and guide prevention. Individuals differ considerably in their medical histories, and current risk assessment approaches could be further improved by incorporating additional information from patients’ health histories. This research project combines nationwide Danish health-register data with clinical skin cancer information to investigate how artificial intelligence can improve individual risk prediction. It also examines potential causal relationships between medication use and skin cancer. The project brings together expertise in dermatology, clinical pharmacology and computer science. Its long-term ambition is to support more personalized prevention and treatment, inform clinical guidelines and explore how risk predictions could assist healthcare professionals through existing clinical systems.
Researcher
Research Assistant Katja Naasunnguaq Jagd 2026-2027
Industrial PhD student (2027-2030)
Project supervisors
Professor Merete Hædersdal
Professor Mads Nielsen, University of Copenhagen
Professor Espen Jimenez-Solem, Bispebjerg Hospital
MD, PhD David Thein, Bispebjerg Hospital
Project period:
01/01/2026 - 01/01/2030
Financing
Danish Research Center for Skin Cancer
Christenson-Cesons Familiefond
Project collaborators
Department of Computer Science (DIKU), University of Copenhagen / Pioneer Centre for AI
Department of Clinical Pharmacology, Bispebjerg Hospital
International collaboration with the Department of Biomedical Informatics, Columbia University, New York.